Merger Notification - Announcement according to § 10 Cartel Act
SANOFI; Blueprint Medicines Corporation
BWB/Z-6965
On 10.06.2025 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
SANOFI (France) intends to indirectly acquire 100% of the shares in and sole control over Blueprint Medicines Corporation (USA).
ÖNACE Code: Manufacture of basic pharmaceutical products
C - MANUFACTURING C 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations, C 21.1 - Manufacture of basic pharmaceutical products, C 21.10 - Manufacture of basic pharmaceutical products
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 08.07.2025.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 09.07.2025 .